Navigation Links
American Capital Receives $60 Million From The Sale Of Lifoam Holdings And Generates An 11% Return On Its Investment

BETHESDA, Md., Jan. 17, 2013 /PRNewswire/ -- American Capital, Ltd. (Nasdaq: ACAS) ("American Capital") announced today that its portfolio company Lifoam Holdings, Inc. ("Lifoam") was sold to Jarden Corporation ("Jarden") (NYSE: JAH) on December 31, 2012.  American Capital received $60 million in debt and equity proceeds and realized a gain of $14 million, subject to post-closing adjustments.  American Capital's compounded annual rate of return earned on its debt and equity securities over the life of its investment was 11%, including interest, dividends, capital gain and fees.  

"American Capital's investment in Lifoam produced an attractive return for our shareholders," said Brian Graff , American Capital Senior Vice President and Senior Managing Director.  "We continue to search for new investment opportunities in a variety of business sectors, either as the sole investor in a One Stop Buyout® or with a sponsor in support of a private equity buyout."

Lifoam is a manufacturer and distributor of expandable polystyrene ("EPS") and polyurethane ("PUR") products for consumer, healthcare and commercial applications.  Lifoam's products include foam picnic coolers, reusable ice and freeze packs and sophisticated protective and thermal packaging products. 

"As a leader in each of its consumer, healthcare and commercial products business segments, Lifoam has demonstrated consistent and strong earnings growth even throughout the recession," said Jim Gregory , American Capital Principal, Buyouts Group.  "American Capital has been fortunate to partner with an exceptional management team, which has driven Lifoam's growth and successful expansion into the highly attractive healthcare cold chain packaging market.  We believe that Lifoam is a great addition to Jarden's business and will benefit from being part of the Jarden family."

Since American Capital's 1997 IPO through the third quarter of 2012, the company has earned a 10% compounded annual return, including interest, dividends, fees and net gains, on over 340 realizations of senior debt, subordinated debt, equity and structured products investments, totaling $18 billion of committed capital.  American Capital earned a 27% compounded annual return on the exit of its equity investments, including dividends, fees and net gains.

For a chart showing a partial listing of American Capital's exited portfolio companies, please go to .  

American Capital is a publicly traded private equity firm and global asset manager.  American Capital, both directly and through its asset management business, originates, underwrites and manages investments in middle market private equity, leveraged finance, real estate and structured products.  American Capital manages $18.6 billion of assets, including assets on its balance sheet and fee earning assets under management by affiliated managers, with $118 billion of total assets under management (including levered assets).  From its eight offices in the U.S. and Europe, American Capital and its affiliate, European Capital, will consider investment opportunities from $10 million to $750 million.  For further information, please refer to

This press release contains forward-looking statements. The statements regarding expected results of American Capital are subject to various factors and uncertainties, including the uncertainties associated with the timing of transaction closings, changes in interest rates, availability of transactions, changes in regional, national or international economic conditions, or changes in the conditions of the industries in which American Capital has made investments.

Brian Graff , Senior Vice President and Senior Managing Director
Dustin Smith , Managing Director, Buyouts Group
Jim Gregory , Principal, Buyouts Group

SOURCE American Capital, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowes, and Seagate
2. Americans United for Life Celebrates Win for Illinois Conscience Rights in Case AUL Championed Since 2005
3. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. American Pacific to Release Financial Results and Hold Fiscal 2012 Year-End and Fourth Quarter Investor Teleconference
6. The American Council for Patient Liberty on medical marijuana vending machines
7. National Community Pharmacists Association and Purdue Pharma Urge Americans to Safeguard Rx Medicines This Holiday Season
8. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
9. Emerging Data on USL261 (Intranasal Midazolam) to Be Presented at the 66th Annual Meeting of the American Epilepsy Society
10. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
11. American Academy of Pain Medicine Safe Opioid Prescribing Course Proves Highly Effective
Post Your Comments:
(Date:10/13/2015)... Regen BioPharma, Inc. , (OTCBB: RGBP, ... , PhD as its new president.  Dr. Lander will work ... as Regen BioPharma prepares to take the next steps ... Regen BioPharma, Inc. , (OTCBB: RGBP, OTC: RGBP) ... as its new president.  Dr. Lander will work closely with ...
(Date:10/13/2015)... HANGZHOU, China , Oct. 13, 2015 ... (the "Company" or " China Jo-Jo "), a leading ... health care products through its own online and retail ... for the Company,s official branded online pharmacy through ... profit margin was a record 25%. ...
(Date:10/13/2015)... World Thrombosis Day Interactive Infographic ...   --> World Thrombosis Day Interactive ... promote vital global awareness of thrombosis, its causes, ... the formation of potentially deadly blood clots in ... thromboembolism (VTE) - or the artery (arterial thrombosis) [1] ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 13, 2015 , ... Vision Group Holdings, the largest LASIK provider in North ... including The LASIK Vision Institute and TLC Laser Eye Centers, Vision Group Holdings has ... vision correction. , Global Laser Vision will continue to operate in San Diego as ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... "My friend's ... his fists into his infected cheeks," said an inventor from Platteville, Colo. "I came ... skin problems." , He developed the UNTOUCHABLE to prevent a child from rubbing or ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a technology company ... health programs and interventions via mobile devices that provide a framework for the ...
(Date:10/13/2015)... ... October 13, 2015 , ... Altec Products, Inc., ... of the Microsoft Dynamics AXUG, GPUG and NAVUG Summits to take place the ... Summit are independent user conferences designed and led by users to provide attendees ...
(Date:10/13/2015)... Williamsport, PA (PRWEB) , ... October 13, 2015 , ... ... (SH) 2015 utility costs were 36 percent lower per square foot than in 2009. ... the actual cost of heating and cooling has decreased by eight percent. , ...
Breaking Medicine News(10 mins):